![](/img/cover-not-exists.png)
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
Koreth, J., Stevenson, K. E., Kim, H. T., Garcia, M., Ho, V. T., Armand, P., Cutler, C., Ritz, J., Antin, J. H., Soiffer, R. J.Volume:
114
Year:
2009
Language:
english
Pages:
4
DOI:
10.1182/blood-2009-07-231092
File:
PDF, 206 KB
english, 2009